Karyopharm Therapeutics KPTI
NASDAQ KPTI
$0.52 -0.03 (-5.45%)
At close: Oct 23, 2026 · 4:00 PM EDT

Karyopharm Therapeutics (KPTI) Return on Equity [ROE] (2013 - 2021)

Updated

Karyopharm Therapeutics' Return on Equity [ROE] came in at -3681.57% for Q1 2021, down 3508.95 percentage points from -172.62% a year earlier and down 3389.31 percentage points from the prior quarter.

Analysis

Karyopharm Therapeutics (KPTI) Return on Equity [ROE] (2013 - 2021) Analysis & Trends

For FY2020, Karyopharm Therapeutics' Return on Equity [ROE] was -391.29%, down 219.93 percentage points from FY2019.

  • Return on Equity [ROE] has declined in each of the last six years, with a five-year change of -332.96 percentage points (FY2015 to FY2020).
  • Going back by year, Return on Equity [ROE] was -171.36% in FY2019 (-57.23 pp), -114.13% in FY2018 (-25.70 pp), -88.43% in FY2017 (-27.66 pp) and -60.77% in FY2016 (-2.44 pp).
  • The Q1 2021 figure represents the lowest quarterly Return on Equity [ROE] in data going back to Q4 2013.
  • Year-over-year, Return on Equity [ROE] increased in three of the last eight quarters, with an average year-over-year change of -484.97 percentage points.
  • The fastest year-over-year change in Return on Equity [ROE] over five years came in Q3 2020 (a gain of 105.18 percentage points), and the weakest in Q1 2021 (a drop of 3508.95 percentage points).
  • Business Quant data shows KPTI's Return on Equity [ROE] at -292.26% (Q4 2020), -188.70% (Q3 2020) and -127.98% (Q2 2020) in the three quarters before Q1 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 82.09%
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 19.33%
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 7.21%
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 31.52%
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 21.39%
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 83.75%
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn -18.38%
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 4.97%
10 Karyopharm Therapeutics 15.05 Mn -211.38 Mn 32.35 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 -3,681.57%
Dec 31, 2020 -292.26%
Sep 30, 2020 -188.70%
Jun 30, 2020 -127.98%
Mar 31, 2020 -172.62%
Dec 31, 2019 -364.07%
Sep 30, 2019 -293.88%
Jun 30, 2019 -211.89%
Mar 31, 2019 -135.40%
Dec 31, 2018 -100.72%
Sep 30, 2018 -82.82%
Jun 30, 2018 -91.78%
Mar 31, 2018 -122.25%
Dec 31, 2017 -95.32%
Sep 30, 2017 -75.83%
Jun 30, 2017 -73.11%
Mar 31, 2017 -74.71%
Dec 31, 2016 -66.49%
Sep 30, 2016 -69.70%
Jun 30, 2016 -70.56%
API Access

Karyopharm Therapeutics Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=KPTI&period=max&api_key=YOUR_API_KEY